Company Update Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Ltd''s wholly owned subsidiary Relonchem Ltd in the UK receives Marketing Authorisation for its product Exemestane 25mg film coated tablet from UK MHRA